These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3934564)

  • 21. The effect of alpha, alpha'-bis[3-(N,N-diethylcarbamoyl)piperidino]-p-xylene on human blood platelet structural physiology.
    Lasslo A; White JG
    Biochim Biophys Acta; 1984 Oct; 777(1):37-40. PubMed ID: 6435673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acquisition and aggregation of canine blood platelets: basic mechanisms of function and differences because of breed origin.
    Clemmons RM; Meyers KM
    Am J Vet Res; 1984 Jan; 45(1):137-44. PubMed ID: 6422804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Time-dependent inhibition of platelet aggregation by dopamine and 3-methoxytyramine. Important roles of their metabolites.
    Kodaira H; Ishikawa M; Komoda Y; Nakajima T
    Biochem Pharmacol; 1984 Feb; 33(3):435-41. PubMed ID: 6422947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of phospholipase inhibitor mepacrine on platelet aggregation, the platelet release reaction and fibrinogen binding to the platelet surface.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    Thromb Haemost; 1981 Jun; 45(3):257-62. PubMed ID: 7281105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of glutathione and other thiols on human platelet aggregation.
    Thomas G; Skrinska VA; Lucas FV
    Thromb Res; 1986 Dec; 44(6):859-66. PubMed ID: 3099423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stored human platelets retain full aggregation potential in response to pairs of aggregating agents.
    DiMinno G; Silver MJ; Murphy S
    Blood; 1982 Mar; 59(3):563-8. PubMed ID: 6800418
    [No Abstract]   [Full Text] [Related]  

  • 27. Vernolepin and platelet aggregation: further studies on the mechanism of action.
    Laekeman GM; De Clerck F; Herman AG; Totté J; Vlietinck A
    Arch Int Pharmacodyn Ther; 1982 Dec; 260(2):284-6. PubMed ID: 7165431
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of the concentration of Ca2+ in the suspending medium on the responses of human and rabbit platelets to aggregating agents.
    Packham MA; Bryant NL; Guccione MA; Kinlough-Rathbone RL; Mustard JF
    Thromb Haemost; 1989 Nov; 62(3):968-76. PubMed ID: 2512683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of flurbiprofen on platelet functions. Study of its interference with the synthesis of platelet thromboxane and production of prostacyclin by the rabbit aorta].
    Levy-Toledano S; Maclouf J; Caen J; Bara L; Lecrubier C; Samama M
    J Pharmacol; 1983; 14(2):141-50. PubMed ID: 6408316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nitroprusside in vitro inhibits platelet aggregation and intracellular calcium translocation. Effect of haemoglobin.
    Pasqui AL; Capecchi PL; Ceccatelli L; Mazza S; Gistri A; Laghi Pasini F; Di Perri T
    Thromb Res; 1991 Jan; 61(2):113-22. PubMed ID: 1902328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bakkenolide G, a natural PAF-receptor antagonist.
    Liao CH; Ko FN; Wu TS; Teng CM
    J Pharm Pharmacol; 1997 Dec; 49(12):1248-53. PubMed ID: 9466352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro effect of the coronary vasodilator diltiazem on human and rabbit platelets.
    Shinjo A; Sasaki Y; Inamasu M; Morita T
    Thromb Res; 1978 Dec; 13(6):941-55. PubMed ID: 107614
    [No Abstract]   [Full Text] [Related]  

  • 33. Possible participation of adenosine 5'-diphosphate, arachidonic acid and paf-acether in the platelet pro-aggregating effect of uncontrolled insulin-dependent diabetic erythrocytes in vitro.
    Juhan-Vague I; Chignard M; Poisson C; Roul C; Billerey M; Buonocore M; Driss F; Vague P; Benveniste J
    Thromb Res; 1985 Apr; 38(1):83-9. PubMed ID: 3923649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Butyltin compounds in vitro inhibition of human platelet epinephrine-induced aggregation and blockade of epinephrine binding to platelets.
    Yanagisawa H; Wada O
    Ind Health; 1985; 23(4):255-68. PubMed ID: 3938784
    [No Abstract]   [Full Text] [Related]  

  • 35. Collagen-induced platelet aggregation: evidence of several mechanisms for the induction of platelet release by collagen.
    Nyman D
    Thromb Res; 1977 May; 10(5):743-51. PubMed ID: 882960
    [No Abstract]   [Full Text] [Related]  

  • 36. A variant form of thrombasthenia.
    Tarantino MD; Corrigan JJ; Glasser L; Payne CM; Jeter MA
    Am J Dis Child; 1991 Sep; 145(9):1053-7. PubMed ID: 1908636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiplatelet effect of butylidenephthalide.
    Teng CM; Chen WY; Ko WC; Ouyang CH
    Biochim Biophys Acta; 1987 Jun; 924(3):375-82. PubMed ID: 3109495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition by a stable analogue of adenosine triphosphate of platelet aggregation by adenosine diphosphate.
    Born GV; Foulks JG
    Br J Pharmacol; 1977 Sep; 61(1):87-9. PubMed ID: 912211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet aggregation measured in rabbit whole blood: in vitro study of 3 aggregating agents and ex vivo inhibition by aspirin and ticlopidine.
    Chevolet C; Grosdent JC; Reiters GM; Dresse A
    Arch Int Pharmacodyn Ther; 1982 Oct; 259(2):310-1. PubMed ID: 6817725
    [No Abstract]   [Full Text] [Related]  

  • 40. Subcellular localization of vasopressin-like material in platelets.
    Chesney CM; Crofton JT; Pifer DD; Brooks DP; Huch KM; Share L
    J Lab Clin Med; 1985 Sep; 106(3):314-8. PubMed ID: 3928782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.